IMMP Relative Valuation
IMMP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, IMMP is overvalued; if below, it's undervalued.
Historical Valuation
Immutep Ltd (IMMP) is now in the Fair zone, suggesting that its current forward PS ratio of 49.08 is considered Fairly compared with the five-year average of -8.84. The fair price of Immutep Ltd (IMMP) is between 2.07 to 5.35 according to relative valuation methord.
Relative Value
Fair Zone
2.07-5.35
Current Price：2.94
Fair
-11.91
PE
1Y
3Y
5Y
-7.54
EV/EBITDA
Immutep Ltd. (IMMP) has a current EV/EBITDA of -7.54. The 5-year average EV/EBITDA is -6.05. The thresholds are as follows: Strongly Undervalued below -11.08, Undervalued between -11.08 and -8.56, Fairly Valued between -3.53 and -8.56, Overvalued between -3.53 and -1.01, and Strongly Overvalued above -1.01. The current Forward EV/EBITDA of -7.54 falls within the Historic Trend Line -Fairly Valued range.
-7.03
EV/EBIT
Immutep Ltd. (IMMP) has a current EV/EBIT of -7.03. The 5-year average EV/EBIT is -6.26. The thresholds are as follows: Strongly Undervalued below -12.04, Undervalued between -12.04 and -9.15, Fairly Valued between -3.37 and -9.15, Overvalued between -3.37 and -0.48, and Strongly Overvalued above -0.48. The current Forward EV/EBIT of -7.03 falls within the Historic Trend Line -Fairly Valued range.
49.08
PS
Immutep Ltd. (IMMP) has a current PS of 49.08. The 5-year average PS is 73.02. The thresholds are as follows: Strongly Undervalued below 4.71, Undervalued between 4.71 and 38.86, Fairly Valued between 107.17 and 38.86, Overvalued between 107.17 and 141.33, and Strongly Overvalued above 141.33. The current Forward PS of 49.08 falls within the Historic Trend Line -Fairly Valued range.
-10.26
P/OCF
Immutep Ltd. (IMMP) has a current P/OCF of -10.26. The 5-year average P/OCF is -8.66. The thresholds are as follows: Strongly Undervalued below -14.47, Undervalued between -14.47 and -11.56, Fairly Valued between -5.75 and -11.56, Overvalued between -5.75 and -2.85, and Strongly Overvalued above -2.85. The current Forward P/OCF of -10.26 falls within the Historic Trend Line -Fairly Valued range.
-9.09
P/FCF
Immutep Ltd. (IMMP) has a current P/FCF of -9.09. The 5-year average P/FCF is -7.53. The thresholds are as follows: Strongly Undervalued below -12.35, Undervalued between -12.35 and -9.94, Fairly Valued between -5.13 and -9.94, Overvalued between -5.13 and -2.72, and Strongly Overvalued above -2.72. The current Forward P/FCF of -9.09 falls within the Historic Trend Line -Fairly Valued range.
Immutep Ltd (IMMP) has a current Price-to-Book (P/B) ratio of 44.83. Compared to its 3-year average P/B ratio of 12.00 , the current P/B ratio is approximately 273.61% higher. Relative to its 5-year average P/B ratio of 8.74, the current P/B ratio is about 412.81% higher. Immutep Ltd (IMMP) has a Forward Free Cash Flow (FCF) yield of approximately -9.80%. Compared to its 3-year average FCF yield of -10.73%, the current FCF yield is approximately -8.71% lower. Relative to its 5-year average FCF yield of -9.27% , the current FCF yield is about 5.70% lower.
44.83
P/B
Median3y
12.00
Median5y
8.74
-9.80
FCF Yield
Median3y
-10.73
Median5y
-9.27
Competitors Valuation Multiple
The average P/S ratio for IMMP's competitors is 15.22, providing a benchmark for relative valuation. Immutep Ltd Corp (IMMP) exhibits a P/S ratio of 49.08, which is 222.5% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of IMMP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IMMP in the past 1 year is driven by Unknown.
People Also Watch
GAU
Galiano Gold Inc
2.64USD
-2.22%
PCYO
Pure Cycle Corp
10.66USD
-1.30%
NVX
NOVONIX Ltd
1.39USD
-6.08%
CCCC
C4 Therapeutics Inc
2.22USD
9.36%
PLBC
Plumas Bancorp
44.25USD
-1.18%
PCB
PCB Bancorp
21.53USD
-0.09%
SATL
Satellogic Inc
2.4USD
9.59%
CBAN
Colony Bankcorp Inc
17.88USD
-0.17%
IMMR
Immersion Corp
6.38USD
-1.69%
FRST
Primis Financial Corp
13.03USD
-0.23%
Frequently Asked Questions
Is Immutep Ltd (IMMP) currently overvalued or undervalued?
Immutep Ltd (IMMP) is now in the Fair zone, suggesting that its current forward PS ratio of 49.08 is considered Fairly compared with the five-year average of -8.84. The fair price of Immutep Ltd (IMMP) is between 2.07 to 5.35 according to relative valuation methord.
What is Immutep Ltd (IMMP) fair value?
IMMP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Immutep Ltd (IMMP) is between 2.07 to 5.35 according to relative valuation methord.
How does IMMP's valuation metrics compare to the industry average?
The average P/S ratio for IMMP's competitors is 15.22, providing a benchmark for relative valuation. Immutep Ltd Corp (IMMP) exhibits a P/S ratio of 49.08, which is 222.50% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Immutep Ltd (IMMP) as of Jan 07 2026?
As of Jan 07 2026, Immutep Ltd (IMMP) has a P/B ratio of 44.83. This indicates that the market values IMMP at 44.83 times its book value.
What is the current FCF Yield for Immutep Ltd (IMMP) as of Jan 07 2026?
As of Jan 07 2026, Immutep Ltd (IMMP) has a FCF Yield of -9.80%. This means that for every dollar of Immutep Ltd’s market capitalization, the company generates -9.80 cents in free cash flow.
What is the current Forward P/E ratio for Immutep Ltd (IMMP) as of Jan 07 2026?
As of Jan 07 2026, Immutep Ltd (IMMP) has a Forward P/E ratio of -11.91. This means the market is willing to pay $-11.91 for every dollar of Immutep Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Immutep Ltd (IMMP) as of Jan 07 2026?
As of Jan 07 2026, Immutep Ltd (IMMP) has a Forward P/S ratio of 49.08. This means the market is valuing IMMP at $49.08 for every dollar of expected revenue over the next 12 months.